Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial

NCT: NCT01604135 · ACTIVE_NOT_RECRUITING

NCT IDNCT01604135
StatusACTIVE_NOT_RECRUITING
Start Date2012-05
Completion2027-04

Brief Summary

The purpose of this study is to determine whether corneal collagen crosslinking is effective in the treatment of progressive keratoconus.

Frequently Asked Questions

What is Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial?

Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial is a clinical trial registered under NCT01604135. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT01604135?

The current status of NCT01604135 (Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial) is: ACTIVE_NOT_RECRUITING.

When did Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial start?

Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial started on 2012-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑